The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented demand.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Related Posts
-
National Balloon Classic crowns new champion to cap 2026 event
Pilots had to navigate some challenging weather conditions throughout the week.
-
Zuckerberg spokesperson says his yacht did not hear call for maritime assist
A yacht owned by Mark Zuckerberg did not hear a radio call for help from…
-
FDA seeks to close decadeslong loophole for food additives
The U.S. Food and Drug Administration has released a long-awaited plan to close a loophole…
-
Day 11 guide to the Iowa State Fair: What to do at the fairgrounds Sunday, Aug. 23
Discount tickets are available for Sunday, Aug. 23, the last day of the Iowa State…
Leave a Reply